134
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Antioxidant activity and photostability assessment of trans-resveratrol acrylate microspheres

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 222-234 | Received 30 Sep 2017, Accepted 18 Mar 2018, Published online: 06 Apr 2018

References

  • Aditya NP, Espinosa YG, Norton IT. 2017. Encapsulation systems for the delivery of hydrophilic nutraceuticals: food application. Biotechnol Adv. 35(4):450–457.
  • Afrasiabi Garekani H, Fatemi Moghaddam Z, Sadeghi F. 2013. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying. Colloids Surf B: Biointerfaces. 108:374–379.
  • Amri A, Chaumeil JC, Sfar S, Charrueau C. 2012. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release. 158:182–193.
  • Andishmand H, Tabibiazar M, Mohammadifar MA, Hamishehkar H. 2017. Pectin-zinc-chitosan-polyethylene glycol colloidal nano-suspension as a food grade carrier for colon targeted delivery of resveratrol. Int J Biol Macromol. 97:16–22.
  • Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5:493–506.
  • Bernard E, Britz-McKibbin P. 2007. Resveratrol photoisomerization: an integrative guided-inquiry experiment. J Chem Educ. 84:1159–1161.
  • Bertacche V, Lorenzi N, Nava D, Pini E, Sinico C. 2006. Host Guest interaction study of resveratrol with natural and modified cyclodextrins. J Incl Phenom Macrocycl Chem. 55:279–287.
  • Billes F, Mohammed-Ziegler I, Mikosch H, Tyihák E. 2007. Vibrational spectroscopy of resveratrol. Spectrochim Acta A: Mol Biomol Spectrosc. 68:669–679.
  • Bodmeier R, Chen H. 1989. Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen. J Contr Rel. 10:167–175.
  • Bolko K, Zvonar A, Gašperlin M. 2014. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility. Drug Dev Ind Pharm. 40:102–109.
  • Bucolo C, Maltese A, Maugeri F, Puglisi G, Busà B, Pignatello R. 2004. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene. J Pharm Pharmacol. 56:841–846.
  • Burns J, Yokota T, Ashihara H, Lean MEJ, Crozier A. 2002. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 50:3337–3340.
  • Camont L, Cottart CH, Rhayem Y, Nivet-Antoine V, Djelidi R, Collin F, Beaudeux JL, Bonnefont-Rousselot D. 2009. Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal Chim Acta. 634:121–128.
  • Carbinatto FM, de Castro AD, Evangelista RC, Cury BSF. 2013. Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci. 9:27–34.
  • Cho AR, Chun YG, Kim BK, Park DJ. 2014. Preparation of chitosan-TPP microspheres as resveratrol carriers. J Food Sci. 79:E568–E576.
  • Chong J, Poutaraud A, Hugueney P. 2009. Metabolism and roles of stilbenes in plants. Plant Sci. 177:143–155.
  • da Rocha Lindner G, Khalil NM, Mainardes RM. 2013. Resveratrol-loaded polymeric nanoparticles: validation of an HPLC-PDA method to determine the drug entrapment and evaluation of its antioxidant activity. Sci World J. https://doi.org/10.1155/2013/506083.
  • Das S, Chaudhury A, Ng KY. 2011b. Polyethyleneimine-modified pectin beads for colon-specific drug delivery: in vitro and in vivo implications. J Microencapsul. 28:268–279.
  • Das S, Ng KY, Ho PC. 2011a. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target. 19:446–457.
  • Deak M, Falk H. 2003. On the chemistry of the resveratrol diastereomers. Monatsh Chem. 134:883–888.
  • Dugave C, Demage L. 2003. Cis-trans isomerization of organic molecules and biomolecules: implications and applications. Chem Rev. 103:2475–2532.
  • Esposito E, Roncarati R, Cortesi R, Cervellati F, Nastruzzi C. 2000. Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics. Pharm Dev Technol. 5:267–278.
  • Figueiras TS, Neves-Petersen MT, Petersen SB. 2011. Activation energy of light induced isomerization of resveratrol. J Fluoresc. 21:1897–1906.
  • Garcia-Perez ME, Royer M, Herbette G, Desjardins Y, Pouliot R, Stevanovic T. 2012. Picea mariana bark: a new source of trans-resveratrol and other bioactive polyphenols. Food Chem. 135:1173–1182.
  • Kashif PM, Madni A, Ashfaq M, Rehman M, Mahmood MA, Khan MI, Tahir N. 2017. Development of Eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies. AAPS PharmSciTech. 18:1810–1822.
  • Kawashima Y, Iwamoto T, Niwa T, Takeuchi H, Hino T. 1993. Size control of ibuprofen microspheres with an acrylic polymer by changing the pH in an aqueous dispersion medium and its mechanism. Chem Pharm Bull. 41:191–195.
  • King RE, Bomser JA, Min DB. 2006. Bioactivity of resveratrol. Comp Rev Food Sci Food Safety. 5:65–70.
  • Librando V, Bracchitta G, De Guidi G, Minniti Z, Perrini G, Catalfo A. 2014. Photodegradation of anthracene and benzo[a]anthracene in polar and apolar media: new pathways of photodegradation. Polycycl Aromat Comp. 34:263–279.
  • Mendes JB, Riekes MK, De Oliveira VM, Michel MD, Stulzer HK, Khalil NM, Zawadzki SF, Mainardes RM, Farago PV. 2012. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Scientific World J. 2012:542937.
  • Montsko G, Nikfardjam MSP, Szabo Z, Boddi K, Lorand T, Ohmacht R, Mark L. 2008. Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC–APCI-MS. J Photochem Photobiol A Chem. 196:44–50.
  • Neves AR, Lucio M, Lima JL, Reis S. 2012. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. CMC. 19:1663–1681.
  • Neves AR, Lúcio M, Martins S, Lima JLC, Reis S. 2013. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Nanomed. 8:177–187.
  • Ninfali P, Mea G, Giorgini S, Rocchi M, Bacchiocca M. 2005. Antioxidant capacity of vegetable, spices and dressing relevant to nutrition. BJN. 93:257–266.
  • Oganesyan EA, Miroshnichenko II, Vikhrieva NS, Lyashenko AA, Leshkov SY. 2010. Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol. Pharm Chem J. 44:74–76.
  • Oliveira CM, Lima FO, Coradini K. 2014. Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur J Pharm Biopharm. 88:178–185.
  • Paolino D, Vero A, Cosco D, Pecora TMG, Cianciolo S, Fresta M, Pignatello R. 2016. Improvement of oral bioavailability of curcumin upon microencapsulation with methacrylic copolymers. Front Pharmacol. 7:485.
  • Pecora TMG, Cianciolo S, Catalfo A, De Guidi G, Ruozi B, Cristiano MC, Paolino D, Graziano ACE, Fresta M, Pignatello R. 2016. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers. J Drug Deliv Sci Technol. 33:88–97.
  • Pignatello R, Amico D, Chiechio S, Giunchedi P, Spadaro C, Puglisi G. Preparation analgesic 2001. activity of Eudragit RS100 microparticles containing diflunisal. Drug Delivery. 8:35–45.
  • Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. 2002b. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 16:53–61.
  • Pignatello R, Bucolo C, Puglisi G. 2002c. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. J Pharm Sci. 91:2636–2641.
  • Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. 2002a. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 23:3247–3255.
  • Pignatello R, Consoli P, Puglisi G. 2000. In vitro release kinetics of tolmetin from tabletted Eudragit microparticles. J Microencapsulation. 17:373–383.
  • Pignatello R, Vandelli MA, Giunchedi P, Puglisi G. 1997. Properties of tolmetin-loaded Eudragit RL100 and RS100 microparticles prepared by different techniques. STP Pharma Sci. 7:148–157.
  • Polyakov N, Leshina T, Kispert L. 2002. Electron transfer mediated geometrical cis-trans isomerization of polyenes. RIKEN Rev. 44:140–143.
  • Renaud S, de Lorgeril M. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523–1526.
  • Scalia S, Trotta V, Iannuccelli V, Bianchi A. 2015. Enhancement of in vivo human skin penetration of resveratrol by chitosan-coated lipid microparticles. Colloids Surf B Biointerfaces. 135:42–49.
  • Sessa M, Tsao R, Liu R, Ferrari G, Donsi F. 2011. Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion. J Agric Food Chem. 59:12352–12360.
  • Sessa N, Balestrieri ML, Ferrari G, Servillo L, Castaldo D, D’Onofrio N, Donsi F, Tsao R. 2014. Bioavailability of encapsulated resveratrol into nanoemulsion based delivery systems. Food Chem. 147:42–50.
  • Singh G, Pai RS. 2014. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential. Expert Opin Drug Deliv. 11:647–659.
  • Singh H, James E, Kan H, Nair LS. 2012. Fabrication and evaluation of resveratrol loaded polymeric nanofibers. J Biomat Tissue Engng. 2:228–235.
  • Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A. 2015. Resveratrol nanoformulations: challenges and opportunities. Int J Pharm. 479:282–290.
  • Teskac J, Kristl J. 2010. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm. 390:61–69.
  • Trela BC, Waterhouse AL. 1996. Resveratrol: Isomeric molar absorptivities and stability. J Agric Food Chem. 44:1253–1257.
  • Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM. 2002. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J. 115:378–380.
  • Wiemers KL, Kauffman JF. 2001. Excited state isomerization kinetics of 4-(methanol) stilbene: application of the isodielectric Kramers-Hubbard analysis. J Phys Chem A. 105:823–828.
  • Xilan S, Yundong S, Weidong Y. 2008. Measurement and correlation of solubilities of trans-resveratrol in ethanol + water and acetone + water mixed solvents at different temperatures. J Chem Eng Data. 53:2562–2566.
  • Zhang WJ, Björn LO. 2009. The effect of ultraviolet radiation on the accumulation of medicinal compounds in plants. Fitoterapia. 80:207–218.
  • Zupancic S, Lavric Z, Kristl J. 2015. Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 93:196–204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.